RE:RE:RE:SuspiciousThey have done foolish things before. You think a company will give them rights to or a cell line for nothing? Vertex bought Semma cells for 1 billion. The way the share price is being held is very suspect. Unless the company is unknown or they aren't looking to acquire cells, it smells fishy to me. Just because the target is 3 doesn't mean it'll happen.
Sailboatdream wrote: With share price targets of $3 by year end (which is in 7 months). Dilution at $1.40 would be absolutely foolish!